Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - HC Wainwright increased their Q3 2026 earnings estimates for shares of Mirum Pharmaceuticals in a report released on Monday, September 28th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of $0.07 per share